Immunotherapy Combo Possibly Linked to Sarcoidosis in Metastatic Melanoma Patient

For the first time, a case of sarcoidosis possibly induced by the use of a combined immunotherapy regimen of Yervoy (ipilimumab) and Opdivo (nivolumab) to treat a patient with metastatic melanoma was reported. The study, published in the Journal for ImmunoTherapy of Cancer, highlights important challenges to diagnosis and disease…